Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
Stockhouse Mar 13 17:15 ET
Intellipharmaceutics Announces Its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the r
AccesswireFeb 26 19:38 ET
Intellipharmaceutics International Inc. Announces Stock Option Grant
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the re
AccesswireFeb 8 16:35 ET
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
Stockhouse Jan 2 17:40 ET
Intellipharmaceutics International GAAP EPS of -$0.06
Seeking AlphaOct 16, 2023 17:30 ET
Intellipharmaceutics International GAAP EPS of $0.00, Revenue of $480.21M
Seeking AlphaJul 17, 2023 10:55 ET
Intellipharmaceutics International Reports FY 2022 and Q1 2023 Results
Seeking AlphaJun 6, 2023 06:24 ET
Intellipharmaceutics International Inc. Brief: Recorded Net Loss for Q1 of US$355,738 or $0.01 per Common Shar
06:05 AM EDT, 06/06/2023 (MT Newswires) -- Intellipharmaceutics International Inc. Brief: Recorded net loss for Q1 of US$355,738 or $0.01 per common shar
MT NewswiresJun 6, 2023 06:05 ET
Intellipharmaceutics International Inc. Brief: Announcing Cease Trade Order
05:14 PM EST, 03/07/2023 (MT Newswires) -- Intellipharmaceutics International Inc. Brief: Announcing Cease Trade Order
MT NewswiresMar 7, 2023 17:16 ET
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Decline in Short Interest
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) was the recipient of a significant drop in short interest in December. As of December 30th, there was short interest total
Financial News LiveJan 19, 2023 10:01 ET
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Update
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) was the target of a large increase in short interest in the month of November. As of November 15th, there was short intere
kopsourceDec 4, 2022 10:31 ET
Intellipharmaceutics GAAP EPS of -C$0.01, Revenue of C$19.06M
Intellipharmaceutics (TSX:IPCI:CA): Q3 GAAP EPS of -C$0.01. Revenue of C$19.06M. As of August 31, 2022, Company cash balance was C$79,649.
Seeking AlphaOct 14, 2022 16:33 ET
Intellipharmaceutics Inks License Deal With Taro for Depression Tablets Desvenlafaxine
Intellipharmaceutics International (OTC:IPCIF) on Tuesday said it had inked a Canadian license and supply agreement with Taro Pharmaceuticals (NYSE:TARO) for depression treatment desvenlafaxine. Share
Seeking AlphaAug 16, 2022 08:55 ET
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Significant Drop in Short Interest
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest tot
Financial News LiveAug 15, 2022 16:21 ET
Intellipharmaceutics International GAAP EPS of -$0.03
Intellipharmaceutics International press release (OTC:IPCIF): Q2 GAAP EPS of -$0.03. As of May 31, 2022, our cash balance was $372,795.
Seeking AlphaJul 21, 2022 17:21 ET
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Short Interest Down 37.3% in March
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 4,700 sh
ETF Daily NewsApr 16, 2022 11:02 ET
Earnings Flash (IPCIF) INTELLIPHARMACEUTICS INTERNATIONAL Reports Q1 Loss $-0.03
Earnings Flash (IPCIF) INTELLIPHARMACEUTICS INTERNATIONAL Reports Q1 Loss $-0.03
MT NewswiresApr 14, 2022 16:36 ET
Intellipharmaceutics International reports Q3 results
Intellipharmaceutics International (OTC:IPCIF): Q3 GAAP EPS of -C$0.04.As of August 31, 2021, our cash balance was C$1.11MPress Release
Seeking AlphaOct 15, 2021 17:28 ET
No Data
No Data